Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Douglas Jones

Surgery Champaign, IL Medical Doctor

NPI 1649287210 CMS profile 1178488

3101 Fields South Dr, Champaign, IL 61822

Open in the dashboard

General payments

$424,637

215 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Douglas Jones of Champaign, IL is reported in the CMS Open Payments database as having received $424,637 across 215 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $188,462 78
2024 General $150,105 55
2023 General $83,109 26
2022 General $1,811 12
2021 General $265 10
2020 General $341 14
2019 General $544 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Douglas Jones
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Douglas Jones were reported at $188,462. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Douglas Jones Surgery median Middle half National median
2019 $544 $253 $82–$1,521 $163
2020 $341 $131 $40–$706 $114
2021 $265 $168 $50–$904 $132
2022 $1,811 $224 $76–$1,218 $149
2023 $83,109 $253 $82–$1,255 $160
2024 $150,105 $279 $90–$1,381 $164
2025 $188,462 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. CSL Plasma Inc. $417,590 125 payments
  2. Davol Inc. $5,424 36 payments
  3. Intuitive Surgical, Inc. $490 10 payments
  4. Smith+Nephew, Inc. $244 10 payments
  5. Integra LifeSciences Corporation $142 4 payments
  6. Organogenesis Inc. $97 3 payments
  7. Acera Surgical, Inc. $81 1 payment
  8. Ethicon US, LLC $80 4 payments
  9. Tactile Systems Technology Inc $57 3 payments
  10. CSL Behring $53 2 payments
  11. Other $378 17 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $417,590 125 payments
  2. Travel and Lodging $3,807 13 payments
  3. Food and Beverage $3,240 77 payments
Products named General payments · program years 2019–2025
  1. Phasix Mesh Surgery $1,607 15 payments
  2. Phasix Mesh BD Interventional Surgery $1,314 8 payments
  3. Da Vinci Surgical System $490 10 payments
  4. ARISTA AH FLEXITIP $215 1 payment
  5. STRAVIX $116 5 payments
  6. Integra Recon-Skin And Wound $116 3 payments
  7. Integra Recon-Skin And Wound $116 3 payments
  8. PRIMATRIX $116 3 payments
  9. Integra Recon-Skin And Wound $116 3 payments
  10. INTEGRA DERMAL REGENERATION TEMPLATE $116 3 payments
  11. Other $1,633 62 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

251

Median for General Surgery: 59

Drug cost

$753

Median for General Surgery: $393

Branded share of claims

43.4%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 109 $414
Gabapentin Generic 60 $117
Cyclobenzaprine Hcl Generic 41 $101
Clindamycin Hcl Generic 11 $88
Metronidazole Generic 11 $19
Tramadol Hcl Generic 19 $14

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 62 billing codes

Paid by Medicare

$51,732

Medicare's payments for the services billed

Medicare patients

143

Average age 71

Services billed

642

86 women, 57 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Diabetes 40%
Ischemic heart disease 34%
Cancer 34%
Heart failure 26%
Depression 26%
Chronic kidney disease 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Zilretta
  • Pacira Pharmaceuticals Incorporated $6
$6 — —
Exparel
  • Pacira Pharmaceuticals Incorporated $6
$6 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

215 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record